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Longmire procedure (hepatojejunostomy) has been 
tried, but with little success, and many do not rec-
ommend it because even in adult cases where car-
cinoma is the underlying obstructive factor, the re-
sult obtained with the Longmire procedure is 
invariably poor and short-lived. The final cure will 
ultimately be in the hands of the geneticist, who 
must prophylactically reduce the number of con-
genital atresia cases that come before the surgeon. 
Figures 42 and 50 show the various operative tech-
niques for congenital atretic lesions amenable to 
surgery. 
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INTRODUCTION 
Orthotopic liver transplantation is the treatment of 
choice for patients with end-stage liver disease. The 
increasing enthusiasm for hepatic transplantation 
during the last decade is the result of better im-
munosuppression, particularly with the introduc-
tion of cyc\osporine in the early 1980s and of 
monoclonal antibodies more recently New im-
provements in technique have made the operation 
more practica\. For these reasons, liver transplan-
tation is no longer considered an experimental 
procedure but rather an accepted mode of therapy 
for patients with hopelessly advanced hepatic dis-
ease. 
The indications for liver transplantation are 
changing constantly In order to benefit more pa-
tients who otherwise would inevitablv die of com-
plications of liver disease, as in fulmin~nt hepatitis. 
Still. an absolute indication ior hepatic transplan-
tation in children is biliarv atresia. 
CLINICAL TRIALS 
The first attempt at hepatic transplantation in a 
human was in 1963. The patient, a 3-year-old boy 
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with biliary atresia, died on the operating table from 
hemorrhage. It was not until 1967 that the first long-
term survival was obtained. A 1.S-year-old girl with 
hepatocellular carcinoma survived for 13 months 
before succumbing to metastatic disease. 
Three years later, a 4-year-old girl with biliary 
atresia and an incidental hepatoma underwent a 
liver transplant; this patient is alive and attending 
college more than 16 years later. 
During the precyc1osporine era from March 1963 
to February 1980, 86 children underwent liver 
replacement, of whom 51 had biliary atresia 
(Table 1). 
Cyc\osporine was introduced in March 1980 and 
since then, there has been a progressive increase 
in the number of liver transplants performed, The 
series began at the University of Colorado and 
continued until 1981, when the program was 
transferred to the University of Pittsburgh. Five 
hundred patients received liver transplants from 
March 1980 to November 1985. There were 203 pe-
diatric recipients, of whom 99 had biliary atresia, 
the most common indication. Other indications for 
hepatic transplantation under cyclosporine therapy 
are listed in Table 2. 
Almost all of the children undergoing liver 
transplantation for bilian' atresia had had at least 
one portoenterostomy procedure (Kasai). Since 
these patients had failed with a biliary drainage 
procedure, the decision for transplantation was 
easy. The children rapidly developed progressive 
hepatic disease manifested by failure to thrive, in-
creasing jaundice, and complications of portal hy-
pertension. 
Table I. Indications for Liwr T ran~plantation 
in Pediatric Patients in thl' Prl'cnlc"porine Era 
Main Indication 
Biliary atresia 
Inborn metabolic errors 
Nonalcoholic cirrhosis 
Primary liver malignancy 
Neonatal hepatitiS 
Congenital hepatic fibrosis 
Secondary biliary cirrhosis' 
Total 
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SURGICAL TECHNIQUES 
Donor Operation 
The technical aspects of the donor hepatectomy and 
preservation have been discussed in detail else-
where. A significant problem in the procurement 
of organs for children is the limited availability of 
small pediatric donors. In extreme circumstances, 
adult livers have been used in children after partial 
resections at the "back table." 
In small donors, it is advisable to leave the celiac 
axis in continuity with the thoracic or abdominal 
aorta or both. This is particularly important when 
the recipient or donor hepatic artery cannot be used 
for the reconstruction, as in the presence of anom-
alous vessels. If the donor abdominal aorta cannot 
be retrieved, the thoradc aorta may be turned down 
180° for anastomosis to the recipient's aorta. A 
useful technique is to transect the thoracic aorta, 
reanastomose it to the aortic cuff below the celiac 
axis, and tailor the transected end of the thoracic 
aorta to form a smooth funnel. This avoids a blind 
pouch, which could be the source of thrombus for-
mation (Fig. 43). It must be emphasized, however, 
that in the presence of a redpient hepatic artery of 
good quality, the best results are obtained when 
an end-ta-end anastomosis is carried out between 
the redpient hepatic artery and the donor celiac 
axis. 
Recipient Operation 
In children, a bilateral subcostal incision, often us-
ing the previous indsion, will suffice. The dissec-
tion is then continued in the hilum of the liver, 
attempting to identify the Roux-en- Y limb of the 
• 
Figure 43. The thoracic aorta is transected above the celiac 
axis and anastomosed below it. The suraceliac cuff is tailored 
Table 2. Indications for Liver Transplantation 
in Pediatric Patients in the Cyclosporine Era 
No. of Patients 
(March J, 1980-
December 1, 
Main Indication 1985) Percent 
Biliary atresia 
Inborn metabolic errors 
Nonalcoholic cirrhosis 
99 
45 
21 
Familial cholestasis 14 
Neonatal hepatitis 6 
Acute hepatic necrosis 5 
Congenital hepatic fibrosis 3 
Secondary biliary cirrhosis 3 
Sclerosing cholangitis 2 
Toxic hepatic injury 2 
Trauma 
Inflammatory pseudotumor 
Budd-Chiari syndrome 
Total 203 
48.8 
22.2 
10.3 
6.9 
3.0 
2.5 
1.5 
1.5 
1.0 
1.0 
0.5 
0.5 
0.5 
100% 
portoenterostomy. This is useful in patients with 
dense adhesions, since dissection of the portoen-
terostomy will aid in exposing the hilar structures 
for proper identification. The hepatic artery should 
be ligated early to minimize bleeding. Then the 
portal is ligated deep into the hilum in order to 
obtain a long vessel. It is better to trim a long portal 
vein during the reconstruction than to come out 
short, necessitating interposition grafts. 
Hepatectomy in children is usually easier than 
in adults. and this is often the case in patients with 
biliary atresIa and a single portoenterostomy pro-
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cl'dure. However, numerous attempts at biliarv 
drainage, creation of stomas, and infection in the 
right upper quadrant can make the hepatectomy 
extremely difficult. Recently, venous bypass has 
been used more frequently and successfully in 
children. Decreased blood loss, stable hemody-
namic physiology during the anhepatic phase, and 
less renal insult are some of the advantages of ven-
ous bypass. It also facilitates the hepatectomy and 
allows more time for hemostasis during the an-
hepatic phase, since the latter is better acl"rieved 
with venous bypass. 
If dissection of the hilar structures is impossible 
because of dense adhesions, encircling the hepa-
toduodenal ligament (Pringle's maneuver) will 
permit en bloc clamping of the portal triad. The 
ligament is then transected, and the vascular 
structures are identified so that they may be dis-
sected more safely. Another valuable maneuver 
employed when adhesions preclude a safe hepa-
tectomy is to clamp the suprahepatic vena cava, 
divide it, and insert one or two fingers into the 
intrahepatic cava to minimize blood loss. The liver 
is then dissected free from above until the infra-
hepatic cava is encountered. Finally, a clamp is 
placed on the infra hepatic cava to obtain vascular 
control. 
The sequence and techniques of the vascular an-
astomoses have been reported elsewhere. Preven-
tion of anastomotic strictures is of the utmost im-
portance. A running suture of monofilament 
material is used, and excessive traction of the suture 
should be avoided. The "growth factor" technique 
is a practical method for eliminating purse string 
at the anastomosis. Upon termination of the anas-
tomOSIS, the suture is tied away from the vessel, 
allowing the anastomosis to expand to its normal 
diameter. The extra suture will work its way into 
the suture line as the anastomosis grows (Fig. 44). 
The biliary reconstruction is performed last when 
satisfactory hemostasis has been accomplished. 
End-to-side anastomosis of the donor common bile 
duct to a Roux-en-Y loop of jejunum with an in-
ternal stent is the technique of choice. This method 
of biliary reconstruction has provided excellent re-
sults even in small bile ducts, as in livers from 
newborns. As previously mentioned, the majority 
of these patients have had portoenterostomies with 
Roux-en-Ys which may be reused if they have not 
been damaged during the dissection. However, the 
old Roux-en-Y has had to be resected in most in-
stances because, with previous revisions, the limb 
has been rendered unsuitable for biliary recon-
struction. 
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IMMUNOSUPPRESSION 
Precyc/osporine Era 
The current immunosuppression therapy for liver 
transplantation was derived from experience with 
renal transplantation, since the latter provided a 
much simpler model with which to work. Combi-
nation therapy with azathioprine and prednisone 
was the first widely used immunosuppressive reg-
imen. However, most of the liver recipients from 
1963 to 1980 in our series were treated with azathio-
prine, prednisone, and antilymphocyte (ALG). Oc-
casionally, cyclophosphamide was substituted for 
azathioprine. Other additions to the immunosup-
pressive therapy, such as thoracic duct drainage, 
had no obvious benefit in hepatic transplantation. 
The overall survival with the triple-drug therapy 
was 32.9% and 20% at 1 and 5 years, respectively. 
Cyclosporine Era 
Cyc\osporine A is derived from two strains of fungi, 
Cylindrocarpomlucidum and Tolypocladium inflatum 
Gams. Cyc\osporine was introduced to transplan-
tation based on the experimental work of Borel et 
aI, and the first clinical trials were performed by 
CaIne et aL Better understanding of its mechanism 
of action has minimized complications such as the 
development of lymphomas and nephrotoxicity. 
Patient mortality has been reduced (Fig. 45). 
In March 1980, cyclosporine and prednisone 
were introduced to the liver transplant program. 
There was a dramatic improvement demonstrated 
by an overall actuarial survival of 69.7'7r and 62.8<;{ 
at 1 and 5 years, respectively. During the last year, 
a 2-week course with the monoclonal OKT3 (Ortho) 
was added to the immunosuppression regimen. 
The first clinical trials with OKB showed re\'ersal 
of steroid-resistant rejE'ction in a high percentage 
of kidney and liver transplant recipients. 
RESULTS (SURVIVAL) 
Precyc/osporille Era 
Eighty-six out of a total of 170 patients underwent 
liver replacement from 1963 to 1980. Fifty-three of 
the 86 died within a year after transplantation. The 
main causes of death are listed in Table 3. There 
was a high incidence of bacterial, fungal, and viral 
infections. Technical complications played an im-
portant role and, in part, were the cause of the 
poor results obtained in patients with biliary atresia 
compared to children with inborn errors of metab-
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Figure 45. Number of patients receiving orthotopic liver 
trallsplants durin!{ thl' cyc/osporhle era. The /lIlIIlber in pa-
renthl'ses represellt retrallsplants per calclldar year. 
olism (Fig. 46). As mentioned before, previous 
surgical procedures in the right upper quadrant 
made the operation more difficult. Additionally, 
anomalies of the portal vein, including thrombosis, 
are frequently observed in patients with advanced 
biliary atresia. The 5-year survival in patients with 
biliary atresia was 14%. 
Cyclosporine Era 
The 5-year actuarial survival for the entire series 
(500 patients) is 6O.6'7c . Of these patients, 203 were 
children (less than 18 years); the 5-year actuarial 
sun;ival in this group is 67.7'1(. The 5-year actuarial 
survival In patients with biliary atresia is shown in 
Figure 47. The period of observation in patients 
Table 3. Chief Causes of Death Within a Year 
After Ht.'patic Transplantation Among 86 
Pediatric Patients in the Precvclosporine Era 
Infection 
Technical complication 
Rejection 
Intra- and perioperative death 
Pnmary graft dysfunction 
Other 
Total 
No. of 
Patients 
20 
15 
9 
3 
3 
3" 
53 
Percent 
of Total 
23.3 
17.4 
10.5 
3.5 
3.5 
3.5 
61.7% 
"One patient died of recurrent malignancy, another from 
pulmonary embolism, and the third from respiratory 
failure secondary to an oversized graft. 
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less than 2 years of age is only 3 years, and the 
actuarial survival is slightly better than that of pa-
tients older than 2 years (Fig. 48). In contrast to 
the precyclosporine experience, there was little 
difference between patients with inborn metabolic 
errors and those with biliary atresia. The narrowing 
of the gap between these two groups of patients 
is explained by the fact that patients on cyclo-
sporine seem to tolerate the perioperative trauma 
better than those on conventional immuno-
suppression. Further, there has been more famil-
iarization with the procedure and better under-
standing of the perioperative metabolic changes as 
the number of transplants increased during the last 
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Figure 48. Actuarial survival of liver transplant recipients 
for biliary artresia under 2 years comparrd to patients over 2 
few years. Although there was an immediate im-
provement in survival when cyclosporine was in-
troduced, there were some early deaths which 
could have been avoided by more effective dose 
control of cyclosporine and by aggressive retrans-
plantation. At present, cyclosporine blood levels 
are monitored daily until the patient is discharged, 
and then twice a week for several weeks until the 
best dosage is reached in order to prevent irrever-
sible rejection or overimmunosuppression. 
Ret rtlllspJalltatlon 
Retransplantation should be strongly considered 
when the allograft is failing. Failure of the graft is 
due to rejection, primary graft dysfunction, or 
technical complications. The most common prob-
lems in the pediatric population are technical, and 
of these, arterial thrombosis is bv far the most fre-
quent reason for retransplantati~nK The causes of 
arterial thrombosis are multifactorial: technical er-
rors, small size of the vessels, overcorrection of 
bleeding with clot-promoting products, infection, 
and rejection. Rejection with swelling of the liver 
may create a low-flow state, which in tum could 
lead to thrombosis. 
The 5-year actuarial survival in children who re-
ceived more than one hepatic transplant is 55.3%. 
Although this survival is not as good as that of 
patients with the first graft, it is high enough to 
justify such efforts when the primary graft has 
failed or is failing. 
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In a recent report, Urbach et al. I showed that 76% 
of 29 children who received liver replacement and 
were followed for at least 2 years had excellent 
growth patterns. This response is explained in part 
by the small doses of steroids needed for immu-
nosuppression when cyclosporine is used in con-
junction. Biliary atresia accounted for 13 out of the 
29 patients. 
Effect of Age 011 SIIn.'li'ai 
The influence of age on survival in the pediatric 
patient population was reviewed by Iwatsuki et al.' 
In the precyclosporine era, 53'7c of infants and pre-
school children (less than 6 years), 50'?, of those 
between 6 and 12 years, and 76'7c of those between 
12 and 18 years lived for more than 3 months. In 
the cyclosporine era, 76'7, of infants and preschool 
children, 67'?c of children between 6 and 12 years 
of age, and 86% of the adolescents lived for more 
than 3 months. The 3-month survival was not in-
fluenced by age either before or after cydosporine 
therapy (Fig. 49). 
CONCLUSIONS 
Biliary atresia is the most common indication for 
hepatic transplantation in the pediatric population. 
Liver replacement is the treatment of choice for 
biliary atresia, and there is no limitation of age or 
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soon as the patient begins to show signs of hepatic 
decompensation. 
The scarcity of small pediatric donors is a most 
important practical factor. Adequate biliary drain-
age may stabilize the patient and buy valuable time. 
A single attempt at portoenterostomy may not add 
any risks to liver transplantation; however, surgical 
procedures of questionable benefit such as revisions 
of portoenterostomies and portosystemic shunts 
should be avoided, since they may jeopardize the 
final option of a hepatic replacement. 
The progress in liver transplantation during the 
last few years has not been explained by better pa-
tient selection. Improvements in surgical tech-
niques in the donor and recipient, aggressive re-
transplantation, and better immunosuppression 
have all played a role. Of these factors, cyc1osporine 
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has had the greatest impact in improving survival 
following hepatic transplantation. 
A Consensus Development Conference held in 
1983 in Maryland concluded that liver transplan-
tation was a service rather than an experimental 
procedure. Liver transplantation is the most ap-
propriate treatment for biliary atresia. If success-
fully treated, these patients can grow and function 
normally. 
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Congenital Cyst of the Conlmon 
Bile Duct (Choledochal Cyst) 
Congenital cyst or choledochal cyst is, as the name 
implies, of congenital origin, idiopathic in nature, 
and rare. It may be small or large, ovoid or round, 
and usually presents in the supraduodenal portion 
of the common bile duct. The cyst mayor may not 
involve the right and left hepatic ducts. The back-
ground for this congenital formation has many 
etiological and theoretical explanations, but none 
has yet been found uniwrsally acceptable. We 
speak of a choledochal cyst, recognize it, and deal 
with it as best we can. This condition is more fre-
quent in the female than in the male, and its size 
may vary from that of a small orange to a grape-
fruit. No one has established any relationship be-
tween the size of the cyst, its duration, and the 
severity of the symptoms. There is no constant re-
lationship between the size of the cyst and the pa-
tient's age. The larger cyst, however, is more often 
seen in the teenage or adult patient. The wall of 
the cyst is usually thick and firm, and is almost 
invariably composed of epithelium; the lining of 
the cyst may be entirely absent, and on frozen sec-
tion the wall may contain fibrous tissue. The size 
of the distal common duct may vary and, more 
often than not, is narrowed. The gallbladder is 
usually of normal size. Regardless of the dilatation 
of the common duct, it is uncommon for stones to 
be found in the gallbladder or CYst; however, stones 
in the cyst have been reported (see Fig. 50). As a 
rule, the intrahepatic ductal system is of normal 
size, but this too ma\' be dIlated on occasion. The 
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Figure SO. Classification of bile duct cysts. Refer to chapter 
on Congenital Cysts of the com mOl! bile duct. T. Tadani de-
scribes his classifications of bile duel cysts. 
